Jie Chen

Jie Chen is the founder of Suzhou Industrial Park Bioventure Investment Management Ltd., founded in 2013, holding the title of Founding Partner.
Current jobs include Business Development Director at A.T.
Kearney, Inc.; Managing Director at CXC Capital, Inc.; Director at Suzhou Kintor Pharmaceuticals, Inc., Zhejiang Kailite Medical Instrument Co., Ltd., Shanghai HXC Industry Co., Ltd., Shenzhen Dymind Biotechnology Co., Ltd. (since 2017), Shenzhen Nanomicro Technology Co. Ltd. (since 2016); Independent Director at Shanghai Kechow Pharma, Inc. (since 2025); Head of China Division at Olympus Capital Holdings Asia LLC; Investment VP at Philips (China) Investment Co. Ltd.; Senior VP at GL Capital Group; and Member-Supervisory Board at Chuanxin Biomedical (Suzhou) Co., Ltd. Former jobs include Independent Director at Sichuan Kelun Pharmaceutical Co., Ltd. (2021–2022); Director at Gege Medical Technology (Shanghai) Co., Ltd. and Shanghai Gongsheng Business Consulting Co. Ltd.; Non-Executive Director at Kintor Pharmaceutical Ltd. (2016–2021) and Shandong Boan Biotechnology Co., Ltd. (2021–2023); General Manager-Guangzhou Branch at Shell (China) Ltd. (1995–1999); Manager-Business Development at Eaton (China) Investments Co. Ltd. (2004–2006); Business Manager at Syngenta (China) Investment Co. Ltd. (2006–2008); and Member-Supervisory Board at Hangzhou AGS MedTech Co., Ltd. Education includes a graduate degree from Cornell University conferred in 2002 and an undergraduate degree from Sun Yat-Sen University conferred in 1995.